Trials / Unknown
UnknownNCT05651464
Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Universität des Saarlandes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective interventional study is to evaluate the impact of antibiotic prophylaxis on bloodstream infections after liberation of extracorporeal membrane oxygenation therapy. The main questions aims to answer are: • does application of vancomycine prior to ECMO liberation have an impact of bloodstream infections? Participants will get 1 dose of vancomycine I.V. (15-20 mg per kgKG) prior to liberation of ECMO. Researchers will compare this interventional group to a group without antibiotic prophylaxis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vancomycine | Application of 15-20 mg per kgKG Vancomycine I.V. prior to ECMO liberation |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-12-15
- Last updated
- 2022-12-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05651464. Inclusion in this directory is not an endorsement.